Phil Dandrea

Phil Dandrea is an experienced medical writing professional with a strong background in regulatory documentation and project leadership. Currently serving as Associate Director of Medical Writing at Corcept Therapeutics since March 2020, Dandrea is responsible for writing and editing regulatory documents and leading medical writing projects, including clinical study protocols, clinical study reports (CSRs), and information brochures (IBs). Previous roles include Associate Director of Medical Writing at Stealth Bio Therapeutics and Principal Medical Writer at Intarcia Therapeutics, where Dandrea authored various regulatory documents and represented the Medical Writing Department in cross-functional meetings. Additional experience includes contract roles at BioBridges and Sanofi-Aventis U.S., as well as a tenure at Biogen as Senior Medical Writer/Senior Document Manager.